Canada's WELL Health 2025 revenue rises 52% on acquisitions, organic growth

WELL Health Technologies

19/03/2026 10:45

((This story was generated using AI and automation, please see
disclaimer https://bit.ly/rtrsnai))
    
    Overview
  
    * Canada digital healthcare firm's fiscal 2025 revenue rose 52% to record C$1.40 bln
    * Adjusted EBITDA for fiscal 2025 jumped 336% to C$203.7 mln, margin improved to 14.5%
    * Company guided 2026 revenue of C$1.55 bln to C$1.65 bln, adjusted EBITDA C$175 mln to C$185 mln

    
    Outlook
  
    * WELL Health sees 2026 revenue between $1.55 bln and $1.65 bln
    * Company expects 2026 Adjusted EBITDA of $175 mln to $185 mln
    * WELL Health targets over $800 mln in Canada revenue and $100 mln Adjusted EBITDA within 18 months

    
    Result Drivers
  
    * ACQUISITIONS - Co said revenue and adjusted EBITDA growth were mainly driven by acquisitions completed over the last twelve months, including 19 clinic transactions
    * ORGANIC GROWTH - Co said organic growth contributed to higher revenue, including 13% organic growth in Canadian Patient Services and growth in WELLSTAR
    * HIGHER-MARGIN BUSINESS MIX - Co attributed improved adjusted gross margin to revenue mix and addition of higher-margin HEALWELL revenue

    
Company press release:  ID:nBw9Xr3na 
    
    Key Details
  
                               
                               
 Metric    Beat/Mis  Actual    Consensu
           s                   s
                               Estimate
                               
                               
 Q4                  C$0.20     
 Adjusted                      
 EPS                           
 Q4                  46.00%     
 Adjusted                      
 Gross                         
 Margin                        
    
    Analyst Coverage
  
    * The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
    * The average consensus recommendation for the healthcare facilities & services peer group is "buy"
    * Wall Street's median 12-month price target for WELL Health Technologies Corp is C$7.50, about 78.1% above its March 18 closing price of C$4.21
    * The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 10 three months ago

    
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)